In this week’s Homerun Slides, a closer look at the workings and efficacy of DPP-4 inhibitors…   To download the complete set in PowerPoint format, just use this link: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 8 Catch up on past …

In this week's Homerun Slides, incretins, an explanation of the glucose-stimulated secretion of insulin and the effect of exenatide versus glargine insulin on insulin secretion in type 2 diabetes...

Dr. Christophe Arbet-Engels explains how Eli Lilly and Boehringer Ingelheim have created and alliance and what that means in terms of promotion.  Christophe Arbet-Engels, MD, PhD, MBA, is vice president, metabolic-clinical development and medical affairs, Boehringer Ingelheim Pharmaceuticals, Inc. See more SGLT-2 Resources